TY - JOUR
T1 - Screening and management of cardiovascular disease in Australian adults with HIV infection
AU - Chan, Derek
AU - Gracey, David
AU - Bailey, Michael John
AU - Richards, Deborah
AU - Dalton, Brad
PY - 2013
Y1 - 2013
N2 - Cardiovascular disease (CVD) is common in HIV infection. With no specific Australian
guidelines for the screening and management of CVD in HIV-infected patients, best clinical practice is based on data
from the general population. We evaluated adherence to these recommendations by primary care physicians who treat
HIV-infected patients. Methods: Primary care physicians with a special interest in HIV infection were asked to complete
details for at least 10 consecutive patient encounters using structured online forms. This included management practices
pertaining to blood pressure (BP), blood glucose, electrocardiogram, lipid profile and CVD risk calculations. We assessed
overall adherence to screening and follow-up recommendations as suggested by national and international guidelines.
Results: Between May 2009 and March 2010, 43 physicians from 25 centres completed reporting for 530 HIV-infected
patients, of whom 93 were male, 25 were aged 41?50 years and 83 were treated with antiretrovirals. Risk factors for
CVD were common and included smoking (38 ), hyperlipidaemia (16 ) and hypertension (28 ). In men aged >40 years
and women aged >50 years without evidence of ischaemic heart disease, only 14 received a CVD risk assessment. Lipid
and BP assessments were performed in 87 and 88 of patients, respectively. Conclusions: This Australian audit
provides unique information on the characteristics and management of HIV and CVD in clinical practice. We have found a
high burden of risk for CVD in HIV-infected Australians, but current screening and management practices in these patients
fall short of contemporary guidelines.
AB - Cardiovascular disease (CVD) is common in HIV infection. With no specific Australian
guidelines for the screening and management of CVD in HIV-infected patients, best clinical practice is based on data
from the general population. We evaluated adherence to these recommendations by primary care physicians who treat
HIV-infected patients. Methods: Primary care physicians with a special interest in HIV infection were asked to complete
details for at least 10 consecutive patient encounters using structured online forms. This included management practices
pertaining to blood pressure (BP), blood glucose, electrocardiogram, lipid profile and CVD risk calculations. We assessed
overall adherence to screening and follow-up recommendations as suggested by national and international guidelines.
Results: Between May 2009 and March 2010, 43 physicians from 25 centres completed reporting for 530 HIV-infected
patients, of whom 93 were male, 25 were aged 41?50 years and 83 were treated with antiretrovirals. Risk factors for
CVD were common and included smoking (38 ), hyperlipidaemia (16 ) and hypertension (28 ). In men aged >40 years
and women aged >50 years without evidence of ischaemic heart disease, only 14 received a CVD risk assessment. Lipid
and BP assessments were performed in 87 and 88 of patients, respectively. Conclusions: This Australian audit
provides unique information on the characteristics and management of HIV and CVD in clinical practice. We have found a
high burden of risk for CVD in HIV-infected Australians, but current screening and management practices in these patients
fall short of contemporary guidelines.
UR - http://www.publish.csiro.au/?act=view_file&file_id=SH13009.pdf
U2 - 10.1071/SH13009
DO - 10.1071/SH13009
M3 - Article
SN - 1448-5028
VL - 10
SP - 495
EP - 501
JO - Sexual Health
JF - Sexual Health
IS - 6
ER -